Franz X Heinz Selected Research

Tick-Borne Encephalitis (Encephalitis, Tick Borne)

1/2021	Dynamics and Extent of Non-Structural Protein 1-Antibody Responses in Tick-Borne Encephalitis Vaccination Breakthroughs and Unvaccinated Patients.
1/2020	Impact of flavivirus vaccine-induced immunity on primary Zika virus antibody response in humans.
1/2020	Extensive flavivirus E trimer breathing accompanies stem zippering of the post-fusion hairpin.
8/2015	Immunization with Immune Complexes Modulates the Fine Specificity of Antibody Responses to a Flavivirus Antigen.
11/2013	Aluminum hydroxide influences not only the extent but also the fine specificity and functional activity of antibody responses to tick-borne encephalitis virus in mice.
9/2013	Tick-borne encephalitis (TBE) and hepatitis B nonresponders feature different immunologic mechanisms in response to TBE and influenza vaccination with involvement of regulatory T and B cells and IL-10.
4/2013	Mechanistic insights into the impairment of memory B cells and antibody production in the elderly.
6/2012	Flaviviruses and flavivirus vaccines.
1/2012	Age affects quantity but not quality of antibody responses after vaccination with an inactivated flavivirus vaccine against tick-borne encephalitis.
11/2008	Effect of pre-existing anti-tick-borne encephalitis virus immunity on neutralising antibody response to the Vero cell-derived, inactivated Japanese encephalitis virus vaccine candidate IC51.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Franz X Heinz Research Topics

Disease

16	Infections 03/2022 - 01/2003
16	Tick-Borne Encephalitis (Encephalitis, Tick Borne) 01/2021 - 04/2002
7	Yellow Fever 01/2020 - 06/2012
6	Dengue (Dengue Fever) 01/2021 - 01/2005
4	Japanese Encephalitis 01/2017 - 11/2008
3	Zika Virus Infection 01/2020 - 01/2018
2	Flavivirus Infections 01/2018 - 08/2015
2	Human Influenza (Influenza) 09/2013 - 08/2007
1	Asymptomatic Infections 01/2020
1	COVID-19 01/2020
1	Virus Diseases (Viral Diseases) 01/2020
1	Hepatitis B 09/2013
1	Genetic Predisposition to Disease (Genetic Predisposition) 09/2013
1	Severe Dengue 06/2012
1	Fever (Fevers) 06/2012

Drug/Important Bio-Agent (IBA)

12	VaccinesIBA 01/2017 - 04/2003
11	Proteins (Proteins, Gene)FDA Link 03/2022 - 06/2002
11	AntibodiesIBA 01/2021 - 01/2005
4	Viral Envelope ProteinsIBA 01/2017 - 04/2003
4	EpitopesIBA 01/2017 - 07/2014
3	Immunoglobulin M (IgM)IBA 01/2021 - 01/2020
3	Neutralizing AntibodiesIBA 01/2017 - 12/2014
2	Peptides (Polypeptides)IBA 01/2020 - 07/2014
2	Immunoglobulin G (IgG)IBA 01/2020 - 11/2008
2	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 01/2018 - 01/2018
2	CytokinesIBA 01/2015 - 09/2013
2	Dengue VaccinesIBA 06/2012 - 01/2005
2	Capsid Proteins (Capsid Protein)IBA 08/2004 - 04/2002
1	AntigensIBA 01/2020
1	Liposomes (Liposome)IBA 09/2017
1	Biological ProductsIBA 09/2017
1	LipidsIBA 09/2017
1	Broadly Neutralizing AntibodiesIBA 01/2016
1	Membrane Proteins (Integral Membrane Proteins)IBA 07/2014
1	Inactivated VaccinesIBA 07/2014
1	Aluminum Hydroxide (Algeldrate)FDA Link 11/2013
1	Influenza Vaccines (Influenza Vaccine)FDA Link 09/2013
1	HLA-DR Antigens (HLA-DR)IBA 09/2013
1	Interleukin-10 (Interleukin 10)IBA 09/2013
1	Interleukin-2 (IL2)IBA 09/2013
1	Attenuated VaccinesIBA 06/2012
1	EnzymesIBA 11/2008
1	ImmunosorbentsIBA 11/2008
1	Hemagglutinins (Hemagglutinin)IBA 08/2007
1	SaltsIBA 08/2004
1	RNA (Ribonucleic Acid)IBA 02/2004
1	Peptide Hydrolases (Proteases)FDA Link 01/2003
1	TrypsinIBA 01/2003
1	FurinIBA 01/2003
1	Glycoproteins (Glycoprotein)IBA 06/2002
1	Amino Acids FDA Link 04/2002

Therapy/Procedure

1	Therapeutics 01/2020